The Language of Care: Unlocking Patient Sentiment with AI

Nandika Techno Analytics Pharma AI Insights Series

AI is no longer an experimental tool in healthcare — it is actively reshaping how pharmaceutical companies work, compete, and care. Leaders like Bayer, Medtronic, and AstraZeneca are already advancing on IMD’s AI Maturity Index, using AI not only for drug discovery but also for listening, learning, and leading with empathy.

Why Traditional HCP Engagement Fails—and How AI is Changing the Game

Nandika Techno Analytics Pharma AI Insights Series

In today’s fast-evolving healthcare landscape, 40% of interactions with healthcare professionals (HCPs) miss the mark—delivering the wrong message, at the wrong time, through the wrong channel. For pharmaceutical and MedTech companies, these missed opportunities translate into $2–3 billion in lost sales annually.

Subscribe to